Medtronic Invests $700M in Cornerstone Robotics for Surgical Robot Rights
Hong Kong – September 07, 2026 -- Medtronic (NYSE: MDT) will invest approximately $700 million in Hong Kong-based Cornerstone Robotics as part of a strategic partnership granting the medtech giant distribution rights to Cornerstone's Sentire surgical robot in select markets outside the United States.
Medtronic secures rights to distribute Sentire in cleared ex-US markets
Under the agreement, Medtronic gains rights to sell the Sentire surgical system in markets where it has already received regulatory clearance. The Sentire system obtained National Medical Products Administration approval in China in 2024, followed by CE marking in the European Union and Health Sciences Authority approval in Singapore in May 2026. All three approvals cover minimally invasive general, gynecological, thoracic and urological procedures.